ResearcherLund UniversityNo recent work listed

Evangelia Sereti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5947-9971; OpenAlex author ID A5033637880. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine? Co-author DOI 10.3390/biomedicines11030890 ↗
Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer? Co-author DOI 10.1016/j.jprot.2018.01.012 ↗
Self-Healing pH- and Enzyme Stimuli-Responsive Hydrogels for Targeted Delivery of Gemcitabine To Treat Pancreatic Cancer. Co-author DOI 10.1021/acs.biomac.8b00959 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Konstantinos S. Dimas · 3 shared papers, 2018–2023 · strength 0.47
Dimitrios E. Magouliotis · 1 shared paper, 2018 · strength 0.08
- Paper Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devas… DOI 10.1016/j.jprot.2018.01.012 ↗
Dimitris Zacharoulis · 1 shared paper, 2018 · strength 0.08
- Paper Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devas… DOI 10.1016/j.jprot.2018.01.012 ↗
Konstantinos Vellios Kamposioras · 1 shared paper, 2018 · strength 0.08
- Paper Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devas… DOI 10.1016/j.jprot.2018.01.012 ↗
Engı̇n Ulukaya · 1 shared paper, 2018 · strength 0.08
- Paper Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devas… DOI 10.1016/j.jprot.2018.01.012 ↗
Hermis Iatrou · 1 shared paper, 2018 · strength 0.08
- Paper Self-Healing pH- and Enzyme Stimuli-Responsive Hydrogels for Targeted Delivery of Gemcitabine To Treat Pancreatic Cance… DOI 10.1021/acs.biomac.8b00959 ↗
Panayiotis Bilalis · 1 shared paper, 2018 · strength 0.08
- Paper Self-Healing pH- and Enzyme Stimuli-Responsive Hydrogels for Targeted Delivery of Gemcitabine To Treat Pancreatic Cance… DOI 10.1021/acs.biomac.8b00959 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.